SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-005825
Filing Date
2020-06-22
Accepted
2020-06-22 09:07:56
Documents
4
Period of Report
2020-06-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_062220.htm 8-K 24299
2 POSTER PRESENTATION ex99-01.htm EX-99.01 1287
3 PRESS RELEASE ex99-02.htm EX-99.02 14538
4 GRAPHIC tonix-img001.jpg GRAPHIC 194108
  Complete submission text file 0001387131-20-005825.txt   303391
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 20977327
SIC: 2834 Pharmaceutical Preparations